Business Context and Reporting Period
This Form 8-K filing by Bio-Rad Laboratories, Inc. (a multinational manufacturer of life science research and clinical diagnostics products) was filed on February 14, 2007. The report primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not contain current period financial statements, revenue, profit, cash flow, or debt metrics. The only historical financial data provided is in the company background section, noting that the company had revenues of $1.1 billion in 2005.
Material Changes
- Board Appointment: Louis Drapeau was appointed to the Board of Directors on February 14, 2007.
- Succession: Mr. Drapeau replaces Philip L. Padou, who passed away late in the prior year.
- Committee Assignment: Mr. Drapeau will serve as a member of the Audit Committee and is designated as a financial expert.
- Compensation: Mr. Drapeau will receive a fee of $2,000 per month, plus $100 per board meeting for meetings in excess of 16 per year, and an additional $625 per month for Audit Committee service.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statement disclaimers regarding risks and uncertainties that could cause results to differ from expectations. No specific financial guidance or outlook for future periods is provided in this document. Mr. Drapeau is scheduled to stand for election at the Annual Meeting of Stockholders on April 24, 2007.
Investor Verification Checklist
- Verify the background and qualifications of Louis Drapeau, particularly his experience as a financial expert and former CFO roles.
- Confirm the date of the Annual Meeting of Stockholders (April 24, 2007) for the formal election of the new director.
- Review the company's most recent 10-K or 10-Q filings for current financial performance, as this 8-K does not contain updated financial data.